ArticleBreast cancer research and treatment2019

Cardiac outcomes of trastuzumab therapy in patients with HER2-positive breast cancer and reduced left ventricular ejection fraction.

Yasin Hussain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.